Status:

COMPLETED

Virtual Integrated Environment in Decreasing Phantom Limb Pain

Lead Sponsor:

Henry M. Jackson Foundation for the Advancement of Military Medicine

Collaborating Sponsors:

Johns Hopkins University

Conditions:

Phantom Limb

Eligibility:

All Genders

18-65 years

Brief Summary

The purpose of this study is to determine if observing a virtual arm decreases phantom limb pain (PLP) in upper extremity amputees.

Detailed Description

Nearly all traumatic limb amputees will experience cognizance of a phantom limb and perceive a vivid impression that their lost limb is not only fully present, but also painful. The John Hopkins Unive...

Eligibility Criteria

Inclusion

  • Male or female subjects, 18 to 65 years of age, active duty military, beneficiary, or retiree.
  • Written informed consent and written authorization for use or release of health and research study information.
  • At least one upper-limb amputation (trans radial or trans humeral) at any time prior to enrollment.
  • No prior history of vertebral disk disease/condition, sciatica or radiculopathy.
  • Normal neurological examination with the exception of limb amputation.
  • Ability to follow study instructions and likely to complete all required visits.
  • Experiencing PLP at least 3 times a week at an intensity of at least 3 out of 10 at the time of enrollment.

Exclusion

  • Presence of mild to severe traumatic brain injury - permanent or temporary impairments of cognitive, physical, and psychosocial functions with an associated diminished or altered state of consciousness - as indicated by neuropsychological screening that is currently performed routinely on patients by the traumatic brain injury (TBI) program at Walter Reed National Military Medical Center (WRNMMC) and noted in the patient's medical record.
  • Known uncontrolled systemic disease
  • Participation (either concurrently or in the 30 days prior to enrollment) in another study for treatment of PLP
  • Any condition or situation that, in the investigator's opinion, may put the subject at significant risk, confound study results, or interfere significantly with the subject's participation in the study.
  • Significant Axis I or II diagnosis determined by a neurologist or psychiatrist in the 6 months prior to entry into the study
  • Subjects with lack of effort as determined by the neurologist or psychiatrist. Subjects will be screened for effort using the Test of Memory Malingering (TOMM) in order to exclude those with blatant exaggeration or malingering. Subjects who score lower than 42/50 on the TOMM-2 will not continue in the study

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2014

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT01462461

Start Date

October 1 2011

End Date

January 1 2014

Last Update

October 16 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Walter Reed National Military Medical Center (WRNMMC)

Bethesda, Maryland, United States, 20889